Rare diseases
Investigational molecules
Locations
Back to Finland28 clinical trials in Espoo, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FinlandKliinisetTutkimukset.fi(opens in a new tab)Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
FinlandStudy of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years
FinlandStudy on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination
FinlandStudy on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers
FinlandStudy on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection
FinlandSafety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children
FinlandStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
FinlandStudy on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults
FinlandStudy on the Safety and Immune Response of PF-07831695 and a Drug Combination for Pneumococcal Infections in Healthy Toddlers Aged 12-15 Months
FinlandStudy on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers
FinlandStudy on the Effectiveness and Safety of OVX836 Vaccine for Preventing Influenza in Healthy Adults Aged 18-59
FinlandStudy on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants
FinlandThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on vaccine development for multiple respiratory viruses, including studies of new formulations against influenza, RSV, and pneumococcal infections. Clinical trials are evaluating innovative immunization approaches for various age groups.
Particular emphasis on protecting vulnerable populations such as infants, toddlers, and adults over 60 years old.
Advanced research in cardiovascular medicine, focusing on preventing stroke in atrial fibrillation patients and developing new treatments for acute myocardial infarction. Studies include innovative drug therapies and preventive measures.
Trials are investigating new anticoagulants and emergency interventions for heart conditions.
Innovative research in surgical procedures and specialized medical conditions, including studies on frostbite treatment, plastic surgery outcomes, and post-operative care protocols.
Focus on improving surgical outcomes and developing better treatment protocols for specialized conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
